Abstract:Background & Objective: New technologies like mobile applications (apps), activity trackers, and continuous glucose monitors (CGM) are available to support people with diabetes (PWD), but it is not clear how these tools are currently used together for diabetes self-management (DSM). This mixed methods study assessed how PWD use technology to relate diabetes self-care behaviors to DSM goals. Methods: Sixty-one adults aged 18-75 with type I or II diabetes (DM) who used ≥1 diabetes medication were surveyed about health app and monitor use (glucose, food, exercise/activity, weight, sleep, and stress trackers) as well as digital and general health literacy. 18 survey respondents completed semi-structured interviews examining how technologies were and could be used in daily DSM. Results: Survey respondents were 34% African American and 38% female, 48% were >45 years old. Regarding DM type and treatment, 72% had Type II diabetes, 59% used insulin, and 56% had used CGMs. Participants had high levels of digital and general health literacy. For tech use, 87% of respondents used ≥1 health app; 59% had used an activity tracker; and 47% had used apps to track ≥3 separate health behaviors. While glucose-tracking apps were more common among CGM (92%) and insulin users (100%), survey respondents used other health apps at similar rates regardless of CGM (57% vs. 60%) or insulin status (61% vs. 60%). Interviewees described using glucose-tracking apps to personalize dietary choices, but less often reported using data from other health apps or monitors for DSM goals. For data to be helpful for DSM, interviewees desired data that was passively collected, easily integrated across monitors, easily visualized, and tailorable to personal health goals. Conclusion: PWD reported using apps to monitor multiple behaviors that impact DSM. Findings suggest that there are untapped opportunities to integrate diabetes apps with trackable lifestyle data to support patient-centered DSM. Disclosure T.M. Bober: None. J.S. Krall: Research Support; Becton, Dickinson and Company, Sanofi. S. Garvin: None. M. Zupa: None. C. White: None. B. Sotaa: None. C. Low: None. A. Rosland: None. Funding The Pittsburgh Foundation (MR2022-128717)

Diabetes Technology in the "Real World": Expanding Access and Addressing Disparities

The Use of Diabetes Technology to Address Inequity in Health Outcomes: Limitations and Opportunities

Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?

Addressing Disparities in Diabetes Management Through Novel Approaches to Encourage Technology Adoption and Use

Making diabetes technology accessible to all

Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology

Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: Key themes and evidentiary gaps

The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice

The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction

Advances in diabetes technology within the digital diabetes ecosystem

A Digital Ecosystem of Diabetes Data and Technology

Removing Barriers, Bridging the Gap, and the Changing Role of the Health Care Professional with Automated Insulin Delivery Systems

Emerging technologies for the management of type 2 diabetes mellitus

Significant publications in diabetes pharmacotherapy and technology in 2020

Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here

Telehealth Technologies in Diabetes Self-management and Education

Use of Technology in the Management and Treatment of Prediabetes, A New Era: A Case Report Series

Telehealth technologies: changing the way we deliver efficacious and cost-effective diabetes self-management education

Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes

564-P: Insights into How Health Technologies Can Support Patient-Centered Diabetes Self-Management—A Mixed-Methods Approach

Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association